EUVIMEDEUVIMED entdecken
Crossref

Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland

Krzysztof Giannopoulos, Krzysztof Jamroziak, Tomasz Wróbel, Dominik Dytfeld

Hematologia · 2022

DOI: 10.5603/hcp.a2022.0007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematologia, 2022. Verfasst von Krzysztof Giannopoulos und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma cell myeloma (PCM) is a hematologic malignancy that derives from mature B cells. The prognosis of patients with PCM is highly dependent on the presence of cytogenetic aberrations. Determination of cytogenetic risk enables informing patients about their prognosis and allows for individual choice of therapy. In Poland, cytogenetic risk assessment is a fully reimbursed procedure, and it is recommended to perform such an examination in every diagnosed patient. Therapy of patients with high cytogenetic risk should be planned with consideration of tandem autotransplantation of hematopoietic cells in eligible patients. In patients with refractory or relapsed PCM, treatment with ixazomib in combination with lenalidomide and dexamethasone appears to remove cytogenetic risk.

Zitieren

APA

Giannopoulos, K., Jamroziak, K., Wróbel, T., & Dytfeld, D. (2022). Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland. Hematologia. https://doi.org/10.5603/hcp.a2022.0007

Vancouver

Giannopoulos K, Jamroziak K, Wróbel T, Dytfeld D. Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland. Hematologia. 2022. doi:10.5603/hcp.a2022.0007

BibTeX
@article{Giannopoulos2022,
  author = {Giannopoulos, Krzysztof and Jamroziak, Krzysztof and Wróbel, Tomasz and Dytfeld, Dominik},
  title = {Optimization of treatment of patients with plasma cell myeloma with high cytogenetic risk in Poland},
  journal = {Hematologia},
  year = {2022},
  doi = {10.5603/hcp.a2022.0007}
}
Kostenlos starten →